Evelyn Partners Investment Management Services Ltd
Position in LLY — ELI LILLY & Co
CIK 2065205
London, X0
Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,231,021
+$171,995 QoQ
Shares Held
8,949
+19.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Evelyn Partners Investment Management Services Ltd holds $132,479,616 across 7 Drug Manufacturers - General names. LLY ranks #3 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
498,147 | $98,244,551 | |
| 2 | JNJ |
Johnson & Johnson
|
103,098 | $25,201,275 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
8,949 | $8,231,021 | |
| 4 | ABBV |
AbbVie Inc.
|
2,410 | $524,150 | |
| 5 | PFE |
Pfizer Inc
|
6,882 | $193,246 | |
| 6 | MRK |
Merck & Co., Inc.
|
608 | $73,136 | |
| 7 | SNY |
Sanofi
|
254 | $12,237 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,231,021 | 8,949 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,059,026 | 7,499 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,560,744 | 7,288 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,238,673 | 1,589 | Shares | Sole | 2025-11-26 | |
| 2025-03-31 | $1,896,289 | 2,296 | Shares | Sole | 2025-12-08 | |
| 2024-12-31 | $630,724 | 817 | Shares | Sole | 2025-12-11 | |
| No filing history on record for this holder in this stock. | ||||||